Home
About
Our Strategy
Meet Our Team
Scientific Advisors
Vive la Liberté
Pipeline
News
Work With Us
Careers
Partnering
Contact
Home
About
Our Strategy
Meet Our Team
Scientific Advisors
Vive la Liberté
Pipeline
News
Work With Us
Careers
Partnering
Contact
Focused
On providing non-opioid pain therapies for rare diseases
Featured news
Featured
Dec 12, 2017
Tremeau and FDA Agree on Phase III Plan for Rofecoxib as Non-Opioid Pain Treatment for Hemophilic Arthropathy
Dec 12, 2017
Dec 12, 2017
Nov 21, 2017
FDA Grants Orphan Drug Designation for TRM-201 (rofecoxib) for the Treatment of Hemophilic Arthropathy
Nov 21, 2017
Nov 21, 2017
